BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 33752316)

  • 21. Oncological Safety of Laparoscopic Surgery for Women with Apparent Early-stage Uterine Clear Cell Carcinoma: A Multicenter Retrospective Cohort Study.
    Hu C; Mao XG; Xu Y; Xu H; Liu Y
    J Minim Invasive Gynecol; 2022 Aug; 29(8):968-975. PubMed ID: 35500748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathologic features and treatment in patients with early stage uterine clear cell carcinoma: A 16-year experience.
    Armbruster SD; Previs R; Soliman PT; Westin SN; Fellman B; Jhingran A; Fleming ND
    Gynecol Oncol; 2019 Aug; 154(2):328-332. PubMed ID: 31221496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant therapy of uterine clear cell carcinoma: a review.
    Xu Y; Hanna RK; Elshaikh MA
    Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.
    You X; Dong Y; Wang J; Cheng Y; Jia Y; Zhang X; Wang J
    BMC Cancer; 2024 Jan; 24(1):99. PubMed ID: 38233757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
    An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
    Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
    Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of positive peritoneal cytology in FIGO stage IB to IIB cervical adenocarcinoma.
    Han Y; Li N; Zhang R; Li X; Sun Y; Wu L
    Int J Gynaecol Obstet; 2017 May; 137(2):150-156. PubMed ID: 28186628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Importance of Lymphovascular Invasion in Uterine Adenosarcomas: Analysis of Clinical, Prognostic, and Treatment Outcomes.
    Nathenson MJ; Conley AP; Lin H; Fleming N; Lazar A; Wang WL; Ravi V
    Int J Gynecol Cancer; 2018 Sep; 28(7):1297-1310. PubMed ID: 30044322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
    Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
    J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
    Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological features and prognostic factors of the uterine sarcomas: 20 years of experience at Cukurova University.
    Khatib G; Guzel AB; Gulec UK; Gumurdulu D; Vardar MA; Altintas A
    Eur J Gynaecol Oncol; 2014; 35(6):646-54. PubMed ID: 25556269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of risk factors of tumor recurrence after liver transplantation for HBV-related hepatocellular carcinoma patients].
    Li Z; Mao YG; Yu C; Gao J; Zhu JY
    Zhonghua Gan Zang Bing Za Zhi; 2018 Feb; 26(2):98-101. PubMed ID: 29804374
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Int J Clin Oncol; 2016 Feb; 21(1):168-76. PubMed ID: 26084780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of preoperative diagnostic hysteroscopy on peritoneal cytology and prognosis in patients with non-endometrioid carcinoma].
    Zhai ZY; Yang L; Li H; Li LW; Shen ZH; Zhang XB; Wang ZQ; Wang JL
    Zhonghua Fu Chan Ke Za Zhi; 2023 Dec; 58(12):903-910. PubMed ID: 38123196
    [No Abstract]   [Full Text] [Related]  

  • 37. Positive peritoneal cytology at interval surgery is a poor prognostic factor in patients with stage T3c advanced ovarian carcinoma: A retrospective study.
    Nagasaka K; Kawana K; Tomio K; Tsuruga T; Mori-Uchino M; Miura S; Tanikawa M; Miyamoto Y; Ikeda Y; Sone K; Adachi K; Matsumoto Y; Arimoto T; Oda K; Osuga Y; Fujii T
    J Obstet Gynaecol Res; 2015 May; 41(5):755-62. PubMed ID: 25421004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 39. Prognostic Factors for Operated Gallbladder Cancer.
    Oven Ustaalioglu BB; Bilici A; Seker M; Kefeli U; Aydin D; Celik S; Demir T; Erkol B
    J Gastrointest Cancer; 2019 Sep; 50(3):451-457. PubMed ID: 29637517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
    Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
    Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.